Bruner JM - Search Results

1

Suppression of human glioma growth by adenovirus-mediated Rb gene transfer.

Fueyo J, Gomez-Manzano C, Yung WK, Liu TJ, Alemany R, Bruner JM, Chintala SK, Rao JS, Levin VA, Kyritsis AP. Fueyo J, et al. Among authors: bruner jm. Neurology. 1998 May;50(5):1307-15. doi: 10.1212/wnl.50.5.1307. Neurology. 1998. PMID: 9595979

2

Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells.

Fueyo J, Gomez-Manzano C, Yung WK, Clayman GL, Liu TJ, Bruner J, Levin VA, Kyritsis AP. Fueyo J, et al. Oncogene. 1996 Jan 4;12(1):103-10. Oncogene. 1996. PMID: 8552379

3

Inhibition of human glioblastoma cell growth by WAF1/Cip1 can be attenuated by mutant p53.

Jung JM, Li H, Kobayashi T, Kyritsis AP, Langford LA, Bruner JM, Levin VA, Zhang W. Jung JM, et al. Among authors: bruner jm. Cell Growth Differ. 1995 Aug;6(8):909-13. Cell Growth Differ. 1995. PMID: 8547219

4

Patterns of expression of Rb and p16 in astrocytic gliomas, and correlation with survival.

Puduvalli VK, Kyritsis AP, Hess KR, Bondy ML, Fuller GN, Kouraklis GP, Levin VA, Bruner JM. Puduvalli VK, et al. Among authors: bruner jm. Int J Oncol. 2000 Nov;17(5):963-9. doi: 10.3892/ijo.17.5.963. Int J Oncol. 2000. PMID: 11029499

5

Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results.

Lang FF, Bruner JM, Fuller GN, Aldape K, Prados MD, Chang S, Berger MS, McDermott MW, Kunwar SM, Junck LR, Chandler W, Zwiebel JA, Kaplan RS, Yung WK. Lang FF, et al. Among authors: bruner jm. J Clin Oncol. 2003 Jul 1;21(13):2508-18. doi: 10.1200/JCO.2003.21.13.2508. J Clin Oncol. 2003. PMID: 12839017 Clinical Trial.

6

Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme.

Levin VA, Maor MH, Thall PF, Yung WK, Bruner J, Sawaya R, Kyritsis AP, Leeds N, Woo S, Rodriguez L, et al. Levin VA, et al. Int J Radiat Oncol Biol Phys. 1995 Sep 30;33(2):357-64. doi: 10.1016/0360-3016(95)00160-Z. Int J Radiat Oncol Biol Phys. 1995. PMID: 7673023 Clinical Trial.

7

The treatment of anaplastic oligodendrogliomas and mixed gliomas.

Kyritsis AP, Yung WK, Bruner J, Gleason MJ, Levin VA. Kyritsis AP, et al. Neurosurgery. 1993 Mar;32(3):365-70; discussion 371. doi: 10.1227/00006123-199303000-00005. Neurosurgery. 1993. PMID: 8455760

8

Mutations of the p16 gene in gliomas.

Kyritsis AP, Zhang B, Zhang W, Xiao M, Takeshima H, Bondy ML, Cunningham JE, Levin VA, Bruner J. Kyritsis AP, et al. Oncogene. 1996 Jan 4;12(1):63-7. Oncogene. 1996. PMID: 8552400

9

Combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas.

Kyritsis AP, Yung WK, Jaeckle KA, Bruner J, Gleason MJ, Ictech SE, Flowers A, Levin VA. Kyritsis AP, et al. Neurosurgery. 1996 Nov;39(5):921-6. doi: 10.1097/00006123-199611000-00006. Neurosurgery. 1996. PMID: 8905746

10

Immunohistochemical localization of plasminogen activator inhibitor type 1 in human brain tumors.

Kono S, Rao JS, Bruner JM, Sawaya R. Kono S, et al. Among authors: bruner jm. J Neuropathol Exp Neurol. 1994 May;53(3):256-62. doi: 10.1097/00005072-199405000-00006. J Neuropathol Exp Neurol. 1994. PMID: 8176408

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters